ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ANIP | RXRX | PVLA | ||
| Company | ANI Pharma Inc | Recursion Pharmaceuticals Inc Cl A | Palvella Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 78.83 | 3.33 | 123.00 | ||
| High | 80.79 | 3.44 | 134.01 | ||
| Low | 78.48 | 3.27 | 120.35 | ||
| Latest | 80.14 | 3.31 | 130.20 | ||
| Change | +1.13 | -0.08 | +7.03 | ||
| % Change | +1.43% | -2.36% | +5.71% | ||
| Volume | 334,500 | 8,765,900 | 356,700 | ||
| 20-Day Average Volume | 391,300 | 13,375,240 | 301,005 | ||
| Previous Close | 79.01 | 3.39 | 123.17 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 74.90 | 3.21 | 120.11 | ||
| 20-Day Raw Stochastic | 83.74% | 70.83% | 71.42% | ||
| 20-Day Relative Strength | 57.38 | 46.73 | 58.14 | ||
| Weighted Alpha | +8.17 | -46.50 | +269.50 | ||
| Today's Opinion | 40% Sell | 88% Sell | 100% Buy | ||
| Previous Opinion | 56% Sell | 88% Sell | 100% Buy | ||
| Last Month's Opinion | 88% Sell | 100% Sell | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +5.50% since 04/01/26 | +8.17% since 04/01/26 | +8.16% since 04/01/26 | ||
| Low | 73.38 on 04/06/26 | 2.93 on 04/02/26 | 112.83 on 04/07/26 | ||
| High | 82.08 on 04/08/26 | 3.45 on 04/08/26 | 134.01 on 04/09/26 | ||
| 1-Month | |||||
| %Chg | +7.12% since 03/09/26 | -5.70% since 03/09/26 | -4.75% since 03/09/26 | ||
| Low | 70.15 on 03/13/26 | 2.80 on 03/30/26 | 108.63 on 03/30/26 | ||
| High | 82.08 on 04/08/26 | 3.57 on 03/10/26 | 143.76 on 03/10/26 | ||
| 3-Month | |||||
| %Chg | +5.06% since 01/09/26 | -28.97% since 01/09/26 | +40.89% since 01/09/26 | ||
| Low | 70.15 on 03/13/26 | 2.80 on 03/30/26 | 72.22 on 01/30/26 | ||
| High | 87.07 on 01/16/26 | 5.24 on 01/22/26 | 151.18 on 02/26/26 | ||
| 6-Month | |||||
| %Chg | -11.72% since 10/09/25 | -43.99% since 10/09/25 | +85.76% since 10/09/25 | ||
| Low | 70.15 on 03/13/26 | 2.80 on 03/30/26 | 65.93 on 10/10/25 | ||
| High | 97.00 on 10/24/25 | 7.18 on 10/20/25 | 151.18 on 02/26/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,770,929 | 1,787,879 | 1,763,055 | ||
| Shares Outstanding, K | 22,414 | 527,398 | 14,314 | ||
| Annual Sales | 883,370,000 | 74,680,000 | 0 | ||
| Annual Net Income | 78,340,000 | -644,760,000 | -41,720,000 | ||
| Last Quarter Sales | 247,060,000 | 35,540,000 | 0 | ||
| Last Quarter Net Income | 27,490,000 | -108,120,000 | -12,710,000 | ||
| 60-Month Beta | 0.44 | 1.02 | -0.21 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 2.33 on 02/27/26 | -0.21 on 02/25/26 | -1.08 on 03/31/26 | ||
| Latest Earnings Date | 05/08/26 | 05/04/26 | 05/21/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 12.48 | 0.00 | 0.00 | ||